Introduction
The incidence of severe depression among women using oral contraceptives is about 5-6%, compared with 1-2% in women using other methods of contraception (Lewis and Hoghughi, 1969; Herzberg and Coppen, 1970; .
There is evidence that women with a history of depression are more likely to develop psychiatric side effects from oral contraceptives. Kaye (1963) reported the cases of three women with severe depression while taking oral contraceptives, two of whom had been under psychiatric care previously. found that women with psychiatric symptoms while taking Anovlar were frequently those who had had medication for psychiatric illness or emotional disturbances during early pregnancy, and Lewis and Hoghughi (1969) also found that women who were depressed while taking oral contraceptives were likely to be those with a history of depression.
In 1968 a prospective study was started to investigate the association between oral contraceptives and changes in mood and libido. In the present paper the incidence of symptoms in women taking oral contraceptives is compared with that in women fitted with an intrauterine device (I.U.D.). Differences between those women who found oral contraceptives satisfactory during the first year and those who experienced adverse effects and stopped or changed their oral contraceptive are also presented.
Further results from the prospective survey will give a full analysis of the individual items of the depression questionnaire.
Methods
The 272 women who participated in the survey attended F.P.A. clinics and were either starting to use oral contraceptives or were being fitted with an I.U.D. All the women had been married for at least six months and had neither given birth nor used oral contraceptives during the previous year; they were between 20 and 45 years of age. Data were collected from the subjects at five consecutive clinic visits.
At the first visit, before using the contraceptive, baseline data were obtained by a standardized questionnaire completed by the interviewing doctor; depression, libido, and personality were assessed by self-rating questionnaires described below. One of three oral contraceptives (Gynovlar, Lyndiol 2-5,* or Norinyl-1) was prescribed or an I.U.D. was fitted. Subsequent visits occurred at intervals of 2, 5, 8, and 11 months from the *The survey began 18 months before the recommendations of the Committee on Safety of Drugs (1970) were circulated. initial visit, when further standardized data were obtained and the self-rating questionnaires were again completed. For all subjects the clinic data were supplemented by depression ratings obtained by postal follow-up and by further information supplied by their general practitioners.
The baseline data consisted of personal measurements (age, height, and weight), family data (date of marriage, husband's age, number of children and their age range), obstetric histories (number of stillbirths, miscarriages), and the presence and duration of depression during pregnancy and postpartum. Further details of the regularity and lengths of menstrual cycles, the incidence and severity of headaches, the age of menarche, and premenstrual symptoms were recorded. All women were asked whether they wished to increase the size of their families at some time. Personal histories of the subjects were noted (birth weight, illness during the first year of life) together with histories of either outpatient or inpatient psychiatric treatment and use of psychotropic drugs and anticonvulsants. Finally, any history of family mental illness and death or separation of parents were noted.
At every subsequent visit the structured questionnaire asked the day of the menstrual cycle, the contraceptive being used, and the number of cycles of use. Any breakthrough bleeding, amenorrhoea, and headaches were recorded, and weights were measured. If the subject had stopped the contraceptive since the last visit a separate questionnaire was completed giving the reasons.
Throughout the survey three questionnaires were used to estimate depression, libido, and personality respectively:
Depression Scale.-This scale for measuring depression was the same as that described in our previous study where its use as a monitor of premenstrual depression was validated . It is a modification of the Beck inventory (Beck et al., 1961) .
BRITISH MEDICAL jouRNAL 28 AUGUST 1971 Libido Scatle.-Three aspects of sexual behaviour were assessed by separate self-rating scales. These were sexual interest, frequency of intercourse, and sexual satisfaction. The full scale is given in the Appendix.
Personality.-A shortened version of the Eysenck Personality Inventory for measuring extraversion and neuroticism was used (Eysenck and Eysenck, 1964) .
Results
The sizes and distribution of age, social class, and parity in the four contraceptive groups are shown in Table I . Nearly one-half of the women were given Norinyl-1 initially and the remainder were divided almost equally between the other three contraceptives. The groups do not have significantly different age or social class distributions but the numbers of children reflect the practice of fitting the I.U.D. only in parous women. There were no significant differences between the different oral contraceptive preparations, and the 272 women were divided into three main groups (Table II) -those who remained on the same contraceptive throughout, those who stopped or changed within the one-year period, and those who failed to attend the follow-up clinics and did not return the postal questionnaire.
The high proportion of women who either stopped or changed their oral contraceptive is surprising-44% of women using oral contraceptives stopped or changed the method during the first year, 37% remained on the same oral contraceptive (Table II) ; by contrast, only 13% of women on the I.U.D.
changed their method of contraception. The proportions in each group for whom information was not complete were about equal.
The composition of the group that stopped or changed oral (30) 7 (20) 19 (38) 34 (27) IV, V 29 (55) 24 (69) 28 (56) 77 (60) IV, V 8 (15) 4 (11) 3 (6) 15 (13 In an attempt to identify depressive effects of oral contraceptives in a non-depressed population the O.C. total group was subdivided into women who were initially "depressed" or "non-depressed," using a dividing score of 9, which corresponded to the mean depression score at visit one. The results are shown in Table V There were no differences between the I.U.D., O.C. throughout, and O.C. stop change groups for age; age of menarche; length of the menstrual cycle; premenstrual symptoms other than weepiness; parental separations, divorce, or death; birth weight; feeding problems or serious illness during first year of life; or use of tranquillizers, sedatives, or night sedation. 
Discussion
In this survey the incidence of changes in women taking oral contraceptives has been compared with that found in a group using the I.U.D. The two methods of contraception are comparable since the I.U.D. provides reversible contraception almost as effective as oral contraceptives (Mills, 1970) and contraception is removed from the act of intercourse. Further, the introduction of an L.U.D. provides a definite point from which changes can be dated. The initial mean depression score of the I.U.D. group was higher than the O.C. total group. This preselection bias may result partly from the well-publicized association between depression and oral contraceptives. The mean depression scores of the O.C. throughout and the I.U.D. groups decreased from the first visit, indicating an improvement of mood which continued beyond the early months. It can be concluded from these two groups of women that there was a slight decrease in the incidence of depressive symptoms after starting a safe method of contraception. The improvement in mood in the O.C. throughout group may result from relief of premenstrual symptoms (Mears and Grant, 1962; Moos, 1968; Herzberg and Coppen, 1970 ). An alternative explanation is a "druginduced" feeling of well-being and mild euphoria in some women, similar to the reactions which sometimes follow administration of corticotrophin or cortisone (Eiduson et al., 1964) .
The mean depression score of the O.C. stop,change group increased from the first to the second visit, in contrast to the other groups. Fig. 2 shows that 500o of this group had increased scores at the second visit compared with 29",, and 240o of the I.U.D. and O.C. throughout groups respectively. The mean depression scores at the third and later visits were lower than the score at the second visit, which indicated that many of the women who experienced adverse changes soon after starting oral contraceptives stopped or changed them with some relief of their symptoms.
The assumption that libido can be measured may be criticized. However, though the rating of three aspects of sexual behaviour-namely, interest, frequency, and satisfaction of intercourse-was by means of a short questionnaire lacking, no doubt, the subtle nature of inquiry by a sympathetic interviewer, the subjects using the different oral contraceptives responded similarly and thus, to some extent, validated the method.
The results in Fig. 3 suggest that starting a safe method of contraception is often followed by increased sexual interest and activity. However, this increase in libido is not maintained in women on oral contraceptives, in contrast to the I.U.D. group, which showed a progressive increase throughout the survey. The women in the O.C. stop/change group showed a slight but progressive decrease in libido throughout the survey. The changes in the O.C. throughout and O.C. stop/change groups support the suggestion that oral contraceptives may have an adverse effect on sexual behaviour (Kane et al., 1967; Nilsson and Solvell, 1967; Michael and Plant, 1969; Huffer et al., 1971 ).
In some women there was an association between loss of libido and depression; those who stopped oral contraceptives because of loss of libido were significantly more depressed initially than those who gave other reasons for stopping.
However, the progressive improvement in mood in the O.C. throughout group contrasts with the pattern of changes seen in the libido ratings, and indicates that the association between mood and libido in women on oral contraceptives may. be complex.
Headaches as a side effect of oral contraceptive medication have been described by several workers (Whitty et al., 1966; British Medical Journal, 1968; Grant and Mears, 1968) . In this series the incidence of severe headaches increased in the O.C. total group, in contrast to the I.U.D. group, where, though the incidence was high initially, it did not increase. The increased incidence of severe headaches in the O.C. throughout group is of particular interest, since it contrasts with the progressive improvement in mood found in this group and suggests that headaches are a side effect which women using oral contraceptives tolerate. It is suggested that headaches may be confined to a few days of the menstrual cycle and consequently may be tolerated.
The results from analysing the data obtained at the first clinic visit indicated that the susceptibility of the individual woman to developing symptoms is probably of greater importance than the composition of the oral contraceptive. Significant differences were found between those women who continued and those who stopped or changed oral contraceptives. A history of depression usually severe and prolonged during pregnancy or premenstrually suggests a sensitivity to hormonal changes associated with increased circulating progesterone. The significantly higher neuroticism scores of the O.C. stop/change group supported the findings of and indicated that there was poor adaptive ability in this group. This was also shown in this survey by the more frequent histories of treatment with antidepressants or outpatient psychiatric visits.
Conclusions
In this survey 37°of women remained on the same oral contraceptive for one year. Though they experienced a progressive improvement in mood, they had an increase in incidence of moderate or severe headaches. Twenty-five per cent. stopped using oral-contraceptives because of side effects, the most common of which were headaches, depression, and loss of libido. The results suggest that some women in this group can be identified from their histories of depression and severe premenstrual weepiness and, where possible, they should be advised to use alternative methods of contraception.
The I.U.D. was acceptable to 74% of women, the only adverse affect being breakthrough bleeding. The improvement in mood and the increase in libido in the I.U.D. group suggest that this is a safe and acceptable method of contraception.
856.
Appendix: Self-rating Scale for Assessing Libido Below are some groups of statements headed I, II, and III. Begin by reading all the statements in group I, and then mark the one statement that best describes how you have been feeling over the last four weeks. Go through groups II and III in the same way. LI Less than once a week.
-I Not had intercourse.
